Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rockwell Medical (RMTI) Shares Outstanding (Diluted Average) (2020 - 2025)

Historic Shares Outstanding (Diluted Average) for Rockwell Medical (RMTI) over the last 8 years, with Q3 2025 value amounting to $36.0 million.

  • Rockwell Medical's Shares Outstanding (Diluted Average) rose 1111.89% to $36.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $36.0 million, marking a year-over-year increase of 1111.89%. This contributed to the annual value of $31.1 million for FY2024, which is 3316.75% up from last year.
  • Rockwell Medical's Shares Outstanding (Diluted Average) amounted to $36.0 million in Q3 2025, which was up 1111.89% from $34.3 million recorded in Q2 2025.
  • In the past 5 years, Rockwell Medical's Shares Outstanding (Diluted Average) registered a high of $36.0 million during Q3 2025, and its lowest value of $8.5 million during Q1 2021.
  • Its 5-year average for Shares Outstanding (Diluted Average) is $21.3 million, with a median of $18.5 million in 2023.
  • Its Shares Outstanding (Diluted Average) has fluctuated over the past 5 years, first plummeted by 8872.52% in 2021, then skyrocketed by 11633.55% in 2022.
  • Over the past 5 years, Rockwell Medical's Shares Outstanding (Diluted Average) (Quarter) stood at $8.5 million in 2021, then soared by 67.77% to $14.3 million in 2022, then surged by 63.05% to $23.3 million in 2023, then surged by 33.17% to $31.1 million in 2024, then grew by 15.99% to $36.0 million in 2025.
  • Its last three reported values are $36.0 million in Q3 2025, $34.3 million for Q2 2025, and $34.1 million during Q1 2025.